These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35387690)

  • 21. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
    Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer.
    Kono S; Miyajima H; Sugimoto M; Suzuki Y; Takahashi Y; Hishida A
    Intern Med; 2001 Sep; 40(9):968-71. PubMed ID: 11579968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebellar ataxia and autoantibodies restricted to glutamic acid decarboxylase 67 (GAD67).
    Guasp M; Solà-Valls N; Martínez-Hernández E; Gil MP; González C; Brieva L; Saiz A; Dalmau J; Graus F; Ariño H
    J Neuroimmunol; 2016 Nov; 300():15-17. PubMed ID: 27806870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
    Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
    J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of immune-mediated encephalopathy showing refractory epilepsy and extensive brain MRI lesions associated with anti-glutamic acid decarboxylase antibody].
    Kobayakawa Y; Tateishi T; Kawamura N; Doi H; Ohyagi Y; Kira J
    Rinsho Shinkeigaku; 2010 Feb; 50(2):92-7. PubMed ID: 20196490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders.
    Powers AC; Bavik K; Tremble J; Daw K; Scherbaum WA; Banga JP
    Clin Exp Immunol; 1999 Dec; 118(3):349-56. PubMed ID: 10594551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibodies specific to the glutamic acid decarboxylase 65 kDa isoform derived from a non-obese diabetic (NOD) mouse.
    Ziegler B; Augstein P; Lühder F; Northemann W; Hamann J; Schlosser M; Klöting I; Michaelis D; Ziegler M
    Diabetes Res; 1994; 25(2):47-64. PubMed ID: 7544254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.
    Zhu Y; Qian L; Liu Q; Zou J; Zhou Y; Yang T; Huang G; Zhou Z; Liu Y
    Diabetes Metab J; 2020 Apr; 44(2):260-266. PubMed ID: 31769235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes.
    De Aizpurua HJ; Wilson YM; Harrison LC
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9841-5. PubMed ID: 1409709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lesson of the month 2: Autoimmune sequelae of anti-GAD antibodies - thinking outside the box.
    Ward RJ; Varughese GI; Jose B; Abraham RJ
    Clin Med (Lond); 2017 Oct; 17(5):473-474. PubMed ID: 28974603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurologic disorders associated with anti-glutamic acid decarboxylase antibodies: A comparison of anti-GAD antibody titers and time-dependent changes between neurologic disease and type I diabetes mellitus.
    Nakajima H; Nakamura Y; Inaba Y; Tsutsumi C; Unoda K; Hosokawa T; Kimura F; Hanafusa T; Date M; Kitaoka H
    J Neuroimmunol; 2018 Apr; 317():84-89. PubMed ID: 29338930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI findings in glutamic acid decarboxylase associated autoimmune epilepsy.
    Fredriksen JR; Carr CM; Koeller KK; Verdoorn JT; Gadoth A; Pittock SJ; Kotsenas AL
    Neuroradiology; 2018 Mar; 60(3):239-245. PubMed ID: 29353399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial autoimmunity in neurological patients with GAD65 antibodies: an interview-based study.
    Muñiz-Castrillo S; Vogrig A; Montagnac C; Joubert B; Benaiteau M; Casez O; Chaumont H; Hopes L; Lanoiselée HM; Navarro V; Thomas B; Ursu R; Gonçalves D; Fabien N; Ducray F; Julier C; Honnorat J
    J Neurol; 2021 Jul; 268(7):2515-2522. PubMed ID: 33544221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fusion proteins for combined analysis of autoantibodies to the 65-kDa isoform of glutamic acid decarboxylase and islet antigen-2 in insulin-dependent diabetes mellitus.
    Rickert M; Seissler J; Dangel W; Lorenz H; Richter W
    Clin Chem; 2001 May; 47(5):926-34. PubMed ID: 11325898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of CD4+ T cells specific for glutamic acid decarboxylase (GAD65) and proinsulin in a patient with stiff-person syndrome but without type 1 diabetes.
    Hänninen A; Soilu-Hänninen M; Hampe CS; Deptula A; Geubtner K; Ilonen J; Knip M; Reijonen H
    Diabetes Metab Res Rev; 2010 May; 26(4):271-9. PubMed ID: 20503259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type 1 diabetes and GAD65 limbic encephalitis: a case report of a 10-year-old girl.
    Grilo E; Pinto J; Caetano JS; Pereira H; Cardoso P; Cardoso R; Dinis I; Pereira C; Fineza I; Mirante A
    J Pediatr Endocrinol Metab; 2016 Aug; 29(8):985-90. PubMed ID: 27115322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous downbeat nystagmus as a clue for the diagnosis of ataxia associated with anti-GAD antibodies.
    Vale TC; Pedroso JL; Alquéres RA; Dutra LA; Barsottini OG
    J Neurol Sci; 2015 Dec; 359(1-2):21-3. PubMed ID: 26671081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The insulin-dependent diabetes mellitus-associated ICA 105 autoantigen in stiff-man syndrome patients.
    Martino G; Grimaldi LM; Bazzigaluppi E; Passini N; Sinigaglia F; Rogge L
    J Neuroimmunol; 1996 Sep; 69(1-2):129-34. PubMed ID: 8823384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GAD65 epitope mapping and search for novel autoantibodies in GAD-associated neurological disorders.
    Fouka P; Alexopoulos H; Akrivou S; Trohatou O; Politis PK; Dalakas MC
    J Neuroimmunol; 2015 Apr; 281():73-7. PubMed ID: 25867471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics of GAD 65-associated autoimmune encephalitis.
    Zhu F; Shan W; Lv R; Li Z; Wang Q
    Acta Neurol Scand; 2020 Sep; 142(3):281-293. PubMed ID: 32416610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.